KIST Developed a core technology for Aqueous Zinc Batteries
Most energy storage systems (ESSs) have recently adopted lithium-ion batteries (LIBs), with the highest technology maturity among secondary batteries. However, these are argued to be unsuitable for ESSs, which store substantial amounts of electricity,...
Boston researcher Ramachandran selected to be inaugural dean of The University of Texas School...
SAN ANTONIO — Vasan Ramachandran, MD, a distinguished public health researcher at Boston University and principal investigator of the Framingham Heart Study, has been named founding dean of The University of Texas School of Public...
Scientists find molecular clues behind acute and chronic phases of traumatic brain injury
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic...
Optimizing Cell Line Construction: How to Find More Needles in a Haystack
Broadcast Date: August 9, 2022Time: 8:00 am PT, 11:00 am ET, 17:00 CET
REGISTER NOW
To meet the demands of ever shorter cell line construction timelines, especially in manufacturing complex protein therapeutics such as bispecific antibodies,...
Biotechnology Market Size Worth US$ ~3,102.94 billion by – GlobeNewswire
Pune, July 22, 2022 (GLOBE NEWSWIRE) -- The global biotechnology market size was pegged at ~US$ 1,032.92 billion in 2021. The market is expected to clock US$ ~3,102.94 billion by 2030, to grow at...
KIST develops key technology for quantum cryptography commercialization
In modern cryptosystems, users generate public and private keys that guarantee security based on computational complexity and use them to encrypt and decrypt information. However, recently, modern public-key cryptosystems have faced potential security loopholes...
Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results – Business...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, August 4, 2022, following the release of its second quarter 2022...
Better Beauty Through Biotechnology? – happi.com
Beauty is better with biotechnology. Arcaea’s announcement that it acquired Gadusol Laboratories, an Oregon State University spinout, is the latest proof that more companies are betting on biotech to solve a range of nagging...
StockWatch: Valneva, Novavax Stocks Swing with COVID-19 Developments
COVID-19 is still top of mind to investors in Valneva and Novavax, two developers of vaccines designed to offer protection, judging from the significant swings in opposite directions shown by the companies’ stock prices...
FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy
The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for an MD Anderson-sponsored Phase I clinical...
